FindTrial
Sign In

Adjuvant chemotherapy for stage I MPA Lung Cancer

Precision diagnosis and treatment for stage I NSCLC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009624
Enrollment
Unknown
Registered
2016-10-26
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Chemotherapy group:Chemotherapy
Control group:Without chemotherapy

Sponsors

Shanghai Pulmonary Hosptial, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients with non small cell lung cancer; 2. The patients aged 18 years to 70 years old; 3. The non-small cell lung cancer patients in I of TNM staging; 4. The non-small cell lung cancer patients with 0-1 in PS scores;

Exclusion criteria

Exclusion criteria: 1. The patients with serious heart, liver, kidney disease; 2. The non-small cell lung cancer patients cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
DFS;—

Secondary

MeasureTime frame
OS;QOL;—

Countries

China

Contacts

Public ContactGening Jiang

Shanghai Pulmonary Hosptial, Tongji University School of Medicine

jgnwp@aliyun.com13003172161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026